test 1 Flashcards
(94 cards)
pyrimidine analogs
fluoruracil, floxuridine, capecitabine, cytarabine, gemcitabine
5-FU use
treatment for GI, pancreas, head & neck, colon, rectum, breast and ovarian cancers
5-FU toxicity
bone marrow suppression, mucosal damage, N/V, cardiac, hand and foot syndrome, alopecia, hyperpigmentation, neurologic deficits
arabinose nucleotides cannot form
phosphodiester bonds bc of the -OH at C2. -> DNA fragmentation
cytarabine (AraC) indication
acute leukemia
most specific antimetabolite for the S phase
cytarabine
cytarabine (AraC) MOA
activated by kinases to AraCTP which acts as an inhibitor of DNA polymerase
side effect of cytarabine
hand and foot syndrome. severe myelosuppression, mucosal membrane inflammation, etc
xeloda generic
capecitabine.
capecitabine indication
breast cancer. prodrug of 5-FU
gemcitabine is used to treat
locally advanced or metastatic pancreatic cancer
triphosphate-gemcitabine inhibits
DNA polymerases (termination of DNA chain elongation)
diphosphate- gemcitabine inhibits
ribonucleotide reductase
nucleotide analogue of the antiviral agent vidarabine
fludaraine
fludarabine MOA
- phosphorylated (inhibition of DNA polymerases)
- incorporation into the DNA strands (chain termination)
purine analogs
6-MP, thioguanine, cladribine, pentostatin
6-mercaptopurine indication
childhood leukemia
both 6-MP and thioguanine are activated by
HGPRT to toxic nucleotides that inhibit several enzymes involved in purine metabolism
reistance to 6-MP and thioguanine
due to cancer cells have decreased HGPRT activity
6-MP is metabolized in the liver by
xanthine oxidase
drug interaction with 6-MP and
allopurinol. if used together, dose of 6-MP should be reduced by at least 75%
ribonucleotide reductase
catalyzes conversion of ribonucleotide diphosphates to deoxyribonucleotide diphosphates
hydroxyurea specifically inhibits
ribonucleotide reductase. inhibits DNA synthesis without affecting RNA synthesis. limited use in cancer
3 antimitotic agents
taxols, vinca alkaloids, colchicine